Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-28T04:32:10.940Z Has data issue: false hasContentIssue false
  • English
  • Français

The epidemiology of recurrent bacterial pneumonia in people with AIDS in Europe

Published online by Cambridge University Press:  04 January 2005

V. PURO ,
D. SERRAINO ,
P. PISELLI ,
E. BOUMIS ,
N. PETROSILLO ,
C. ANGELETTI  and
G. IPPOLITO
V. PURO
Affiliation:
Department of Epidemiology, National Institute for Infectious Diseases, L. Spallanzani, IRCCS, Via Portuense 292, 00149 Rome
D. SERRAINO
Affiliation:
Department of Epidemiology, National Institute for Infectious Diseases, L. Spallanzani, IRCCS, Via Portuense 292, 00149 Rome
P. PISELLI
Affiliation:
Department of Epidemiology, National Institute for Infectious Diseases, L. Spallanzani, IRCCS, Via Portuense 292, 00149 Rome
E. BOUMIS
Affiliation:
Second Division of Infectious Diseases, National Institute for Infectious Diseases, L. Spallanzani, IRCCS, Via Portuense 292, 00149 Rome
N. PETROSILLO
Affiliation:
Second Division of Infectious Diseases, National Institute for Infectious Diseases, L. Spallanzani, IRCCS, Via Portuense 292, 00149 Rome
C. ANGELETTI
Affiliation:
Department of Epidemiology, National Institute for Infectious Diseases, L. Spallanzani, IRCCS, Via Portuense 292, 00149 Rome
G. IPPOLITO
Affiliation:
Department of Epidemiology, National Institute for Infectious Diseases, L. Spallanzani, IRCCS, Via Portuense 292, 00149 Rome
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Data from AIDS surveillance systems in the World Health Organization European region (1993–2001) were analysed to describe the main epidemiological aspects of recurrent bacterial pneumonia (RBP) as AIDS-defining illness (ADI) in Europe. Among the 153756 AIDS cases analysed, 5796 (3·8%) had RBP. The proportion of RBP was higher (8·3%) in eastern than in western Europe (3·6%), possibly because of a greater propensity of certain countries to diagnose RBP. In western Europe, the proportion of RBP as ADI appeared to increase over time up to 1998 (from 2·5% to 4·5%), and declined thereafter (3·3% in 2001). RBP was strongly associated with intravenous drug use (odds ratio 3·0, 95% CI 2·7–3·3), whereas it did not differ in age groups or geographical areas. The study findings confirm the crucial role of intravenous drug use in the occurrence of RBP and suggest that highly active antiretroviral therapies might have had a postponing impact on the relative frequency of RBP as ADI.

Type
Research Article
Information
Epidemiology & Infection , Volume 133 , Issue 2 , April 2005 , pp. 237 - 243
Copyright
© 2004 Cambridge University Press